Effects of Isoproterenol and Neostigmine on Colon Cancer in Rats
Author Information
Author(s): M. Tatsuta, H. Iishil, H. Yamamural, M. Babal, H. Taniguchi
Primary Institution: The Center for Adult Diseases, Osaka
Hypothesis
The autonomic nervous system influences the growth of colonic tumors.
Conclusion
Prolonged administration of isoproterenol and neostigmine significantly decreased the incidence and number of colonic tumors in rats.
Supporting Evidence
- Isoproterenol treatment resulted in a significant decrease in the incidence of colonic tumors.
- Neostigmine significantly decreased the labelling indices of colonic mucosa during carcinogen treatment.
- Colonic tumors were primarily adenocarcinomas in the control group.
Takeaway
This study found that certain medications can help reduce the growth of colon cancer in rats.
Methodology
Young male Wistar rats were treated with isoproterenol and neostigmine before and during carcinogen treatment, and tumor development was monitored.
Limitations
The study was conducted on rats, which may not fully represent human responses.
Participant Demographics
Young male Wistar rats weighing 80-90g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website